Claio est un scribe IA conçu pour les professionnels de la santé afin de rationaliser la documentation clinique. Il transcrit les visites de patients en temps réel, génère instantanément des notes cliniques précises et des codes de facturation, et s'intègre parfaitement aux DSE existants via copier-coller, garantissant la conformité HIPAA et réduisant la charge administrative.
ScribeMD est un scribe médical IA conforme à la norme HIPAA, conçu pour les professionnels de la santé. Il automatise la prise de notes cliniques en écoutant les interactions avec les patients, en les transcrivant et en générant une documentation structurée. Cela permet aux médecins de réduire leur charge de travail administrative, de gagner un temps considérable par patient et de se concentrer davantage sur les soins aux patients.
Claio est un scribe IA conçu pour les professionnels de la santé afin de rationaliser la documentation clinique. Il transcrit les visites de patients en temps réel, génère instantanément des notes cliniques précises et des codes de facturation, et s'intègre parfaitement aux DSE existants via copier-coller, garantissant la conformité HIPAA et réduisant la charge administrative.
ScribeMD est un scribe médical IA conforme à la norme HIPAA, conçu pour les professionnels de la santé. Il automatise la prise de notes cliniques en écoutant les interactions avec les patients, en les transcrivant et en générant une documentation structurée. Cela permet aux médecins de réduire leur charge de travail administrative, de gagner un temps considérable par patient et de se concentrer davantage sur les soins aux patients.
| Feature | Claio | ScribeMD |
|---|---|---|
| Catégorie principale | Aide-soignant(e) | Documentation Médicale |
| Ajouté | 2025-10-22 | 2025-08-10 |
| Tarification | Freemium | Payant |
| Site officiel | www.claio.ai | www.scribemd.ai |
| Type de produit | Site web | Site web |
| Performance data | ||
| Note utilisateur | Non vérifié | Non vérifié |
| Commentaires | 0 | 0 |
| Visites mensuelles | 4.2K | 4.5K |
| Croissance mensuelle | -68.1% | 21.4% |
| Favoris | 131 | 104 |
| Details | Voir les détails | Voir les détails |
Compare Claio and ScribeMD by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
In the Claio vs ScribeMD monthly traffic comparison, Claio currently shows 4.2K visits and ScribeMD shows 4.5K; the two products have similar visible traffic, an absolute difference of about 364 visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 100% | 4.2K |
| Source type | Percentage | Traffic |
|---|---|---|
| Direct | 100% | 4.2K |
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 84.66% | 3.8K |
| 🇪🇸Spain | 14.21% | 644 |
| 🇮🇳India | 1.13% | 51 |
This in-depth Claio vs ScribeMD comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. Claio is primarily listed under “Aide-soignant(e)”, while ScribeMD is primarily listed under “Documentation Médicale”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (Claio: Aide-soignant(e); ScribeMD: Documentation Médicale); Pricing (Claio: Freemium; ScribeMD: Paid); Monthly visits (Claio: 4.2K; ScribeMD: 4.5K); Monthly growth (Claio: -68.1%; ScribeMD: 21.4%); Favorites (Claio: 131; ScribeMD: 104). These facts are more useful for selection than brand visibility alone.
In the Claio vs ScribeMD monthly traffic comparison, Claio currently shows 4.2K visits and ScribeMD shows 4.5K; the two products have similar visible traffic, an absolute difference of about 364 visits. This reflects visible reach, not feature quality or paid users.
Both tools provide verified traffic details, so monthly trends, visit depth, regions, and acquisition sources can be compared on the same basis.
The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Claio and ScribeMD currently overlap in shared categories: Documentation Médicale et Transcription; shared tags: IA en santé, Conforme à la HIPAA et transcription médicale. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
Claio's unique categories/tags are Aide-soignant(e), Facturation et Codage, Notes Cliniques, Scribe IA, réduction du burn-out, Notes cliniques, Intégration DME et Productivité des soins de santé; ScribeMD's are Automatisation, Documentation clinique, Productivité médicale, Automatisation EMR, scribe médical, Notes du patient et Voix vers texte. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
Claio has no verified rating, 0 comments, 131 favorites, and 127 likes；ScribeMD has no verified rating, 0 comments, 104 favorites, and 124 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Put Claio on the priority trial list when the task aligns with “Aide-soignant(e)” and especially Aide-soignant(e), Facturation et Codage, Notes Cliniques, Scribe IA, réduction du burn-out et Notes cliniques, or the users include Cliniciens, Dentistes, Diététiciens et Professionnels de la santé. This follows recorded positioning and does not imply unlisted capabilities are absent.
Claio also currently records: pricing is freemium, product type is website, 4.2K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
Put ScribeMD on the priority trial list when the task aligns with “Documentation Médicale” and especially Automatisation, Documentation clinique, Productivité médicale, Automatisation EMR, scribe médical et Notes du patient. This follows recorded positioning and does not imply unlisted capabilities are absent.
ScribeMD also currently records: pricing is paid, product type is website, 4.5K verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in Claio and ScribeMD, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.
